Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.
Shapira S, Ben Shimon M, Hay-Levi M, Shenberg G, Choshen G, Bannon L, Tepper M, Kazanov D, Seni J, Lev-Ari S, Peer M, Boubas D, Stebbing J, Tsiodras S, Arber N. Shapira S, et al. Among authors: tsiodras s. EMBO Mol Med. 2022 Sep 7;14(9):e15997. doi: 10.15252/emmm.202215997. Epub 2022 Jul 13. EMBO Mol Med. 2022. PMID: 35776000 Free PMC article.
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
Evangelou K, Veroutis D, Paschalaki K, Foukas PG, Lagopati N, Dimitriou M, Papaspyropoulos A, Konda B, Hazapis O, Polyzou A, Havaki S, Kotsinas A, Kittas C, Tzioufas AG, de Leval L, Vassilakos D, Tsiodras S, Stripp BR, Papantonis A, Blandino G, Karakasiliotis I, Barnes PJ, Gorgoulis VG. Evangelou K, et al. Among authors: tsiodras s. Eur Respir J. 2022 Aug 18;60(2):2102951. doi: 10.1183/13993003.02951-2021. Print 2022 Aug. Eur Respir J. 2022. PMID: 35086840 Free PMC article.
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
Galani IE, Rovina N, Lampropoulou V, Triantafyllia V, Manioudaki M, Pavlos E, Koukaki E, Fragkou PC, Panou V, Rapti V, Koltsida O, Mentis A, Koulouris N, Tsiodras S, Koutsoukou A, Andreakos E. Galani IE, et al. Among authors: tsiodras s. Nat Immunol. 2021 Jan;22(1):32-40. doi: 10.1038/s41590-020-00840-x. Epub 2020 Dec 4. Nat Immunol. 2021. PMID: 33277638
The COVID-19 pandemic as inspiration to reconsider epidemic models: A novel approach to spatially homogeneous epidemic spread modeling.
Kostoglou M, Karapantsios T, Petala M, Roilides E, Dovas CI, Papa A, Metallidis S, Stylianidis E, Lytras T, Paraskevis D, Koutsolioutsou-Benaki A, Panagiotakopoulos G, Tsiodras S, Papaioannou N. Kostoglou M, et al. Among authors: tsiodras s. Math Biosci Eng. 2022 Jul 11;19(10):9853-9876. doi: 10.3934/mbe.2022459. Math Biosci Eng. 2022. PMID: 36031972 Free article.
Immune Thrombocytopenia in a Patient Recovering From COVID-19.
Metallidis S, Gioula G, Papaioannou M, Exindari M, Chrysanthidis T, Tsachouridou O, Mimtsoudis I, Christoforidi M, Zempekakis P, Papa-Konidari A, Tsiodras S. Metallidis S, et al. Among authors: tsiodras s. Hemasphere. 2020 Sep 30;4(5):e419. doi: 10.1097/HS9.0000000000000419. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33134859 Free PMC article. No abstract available.
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Martín-Quirós A, Paño-Pardo JR, Power N, Sibani M, Szabo B, Tsiodras S, Zollner-Schwetz I, Rodriguez-Baño J; ESCMID COVID-19 Treatment Guidelines Panel. Bartoletti M, et al. Among authors: tsiodras s. Clin Microbiol Infect. 2022 Apr;28(4):617-618. doi: 10.1016/j.cmi.2021.12.025. Epub 2022 Jan 10. Clin Microbiol Infect. 2022. PMID: 35026374 Free PMC article. No abstract available.
356 results